Sponsor Pipeline

yilong Wang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Early Phase 1
2
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07476352 Expansion Study of ALT001 in Patients With Multiple System Atrophy Multiple System Atrophy Not Yet Recruiting
NCT07514923 The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System… Multiple System Atrophy - Cerebellar Subtype (MSA-C) Not Yet Recruiting
Not specified
NCT06374667 The Efficacy and Safety of Y-3 Intracalvariosseous Injection Versus Intravenous Injection… Stroke, Acute Ischemic Recruiting
NCT07495150 Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial… Blood-Brain Barrier Not Yet Recruiting
NCT07514949 The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the… Stroke Not Yet Recruiting
Disease Areas
Get alerts when yilong Wang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free